Metabolic Characterization of Drug Resistance to Antifolate in Malignant Pleural Mesothelioma

被引：0
|
作者：
Sato, Y. [1 ]
Makinoshima, H. [1 ]
机构：
[1] Natl Canc Ctr, Tsuruoka Metabol Lab, Tsuruoka, Yamagata, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
Mesothelioma; TYMS; Metabolomics;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P25.01
引用
收藏
页码：S381 / S381
页数：1
相关论文
共 50 条
  • [1] Metabolic Characterization of Antifolate Responsiveness and Non-responsiveness in Malignant Pleural Mesothelioma Cells
    Sato, Yuzo
    Matsuda, Shiori
    Maruyama, Ami
    Nakayama, Joji
    Miyashita, Tomoyuki
    Udagawa, Hibiki
    Umemura, Shigeki
    Yanagihara, Kazuyoshi
    Ochiai, Atsushi
    Tomita, Masaru
    Soga, Tomoyoshi
    Tsuchihara, Katsuya
    Makinoshima, Hideki
    [J]. FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [2] Apoptosis regulation and drug resistance in malignant pleural mesothelioma
    Zangemeister-Wittke, U
    Hopkins-Donaldson, S
    [J]. LUNG CANCER, 2005, 49 : S105 - S108
  • [3] Alectinib/lorlatinibAcquired drug resistance in malignant pleural mesothelioma: case report
    [J]. Reactions Weekly, 2020, 1814 (1) : 19 - 19
  • [4] Drug carrier nanosystems in malignant pleural mesothelioma
    Turgut Cosan, Didem
    Ak, Guntulu
    Dag, Ilknur
    Soyocak, Ahu
    Dikmen, Gokhan
    Dal, Aylin
    Gunes, Hasan V.
    Metintas, Muzaffer
    [J]. TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2016, 64 (01): : 60 - 68
  • [5] Anoikis resistance in malignant pleural mesothelioma cells
    Daubriac, J.
    Fleury-Feith, J.
    Jaurand, J. M. C.
    [J]. LUNG CANCER, 2006, 54 : S24 - S24
  • [6] Integrative Molecular Characterization of Malignant Pleural Mesothelioma
    Hmeljaki, Jutija
    Sanchez-Vega, Francisco
    Hoadley, Katherine A.
    Shih, Juliann
    Stewart, Chip
    Heiman, David
    Tarpeyg, Patrick
    Danitova, Ludmila
    Drill, Esther
    Gibb, Ewan A.
    Bowlby, Reanne
    Kanchil, Rupa
    Osmanbeyoglull, Hatice U.
    Sekido, Yoshitaka
    Takeshita, Jumpei
    Newton, Yulia
    Graim, Kiley
    Gupta, Manaswi
    Gaylg, Cart M.
    Diaol, Lixia
    Gibbs, David L.
    Thorsson, Vesteinn
    Lype, Lisa
    Kanthetir, Havish
    Severson, David T.
    Ravegnini, Gloria
    Desrneules, Patrice
    Jungbluth, Achim A.
    Travis, William D.
    Dacic, Sanja
    Chirieac, Lucian R.
    Galateau-Salle, Francoise
    Fujimoto, Junya
    Husain, Aliya N.
    Silveira, Henrique C.
    Rusch, Valerie W.
    Rintoul, Robert C.
    Pass, Harvey
    Kindler, Heciy
    Zauderer, Marjorie G.
    Kwiatkowski, David J.
    Bueno, Raphael
    Tsaols, Anne S.
    Creaney, Jenette
    Lichtenberg, Tara
    Leraas, Kristen
    Bowen, Jay
    Felau, Ina
    Zenklusen, Jean Claude
    Akbanil, Rehan
    [J]. CANCER DISCOVERY, 2018, 8 (12) : 1548 - 1565
  • [7] Metabolic rewiring and redox alterations in malignant pleural mesothelioma
    Loredana Urso
    Ilaria Cavallari
    Evgeniya Sharova
    Francesco Ciccarese
    Giulia Pasello
    Vincenzo Ciminale
    [J]. British Journal of Cancer, 2020, 122 : 52 - 61
  • [8] Metabolic rewiring and redox alterations in malignant pleural mesothelioma
    Urso, Loredana
    Cavallari, Ilaria
    Sharova, Evgeniya
    Ciccarese, Francesco
    Pasello, Giulia
    Ciminale, Vincenzo
    [J]. BRITISH JOURNAL OF CANCER, 2020, 122 (01) : 52 - 61
  • [9] Pemetrexed (Alimta, MTA, multitargeted antifolate, LY231514) for malignant pleural mesothelioma
    Manegold, C
    [J]. SEMINARS IN ONCOLOGY, 2003, 30 (04) : 32 - 36
  • [10] Characterization and drug sensitivity profiling of primary malignant mesothelioma cells from pleural effusions
    Szulkin, Adam
    Otvos, Rita
    Hillerdal, Carl-Olof
    Celep, Aytekin
    Yousef-Fadhel, Eviane
    Skribek, Henriette
    Hjerpe, Anders
    Szekely, Laszlo
    Dobra, Katalin
    [J]. BMC CANCER, 2014, 14
12345